Myocardial hypertrophy is not a prerequisite for changes in early gene expression in left ventricular volume overload

Fundamental and Clinical Pharmacology

Volumn 18, Issue 1, 2004, Pages 39-44

  Dzimiri, Nduna ^a   Al Bahnasi, Kholod ^a   Al Halees, Zohair ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

c fos; c jun; c myc; Dilated cardiomyopathy; Human myocardium; Left ventricular volume overload

Indexed keywords

GENE PRODUCT; MYC PROTEIN; PROTEIN C FOS; STRESS ACTIVATED PROTEIN KINASE;

ADULT; AORTA VALVE REGURGITATION; ARTICLE; C JUN GENE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE; GENE EXPRESSION; GENE FUNCTION; GENE LOCATION; HEART ATRIUM; HEART FAILURE; HEART LEFT VENTRICLE OVERLOAD; HEART LEFT VENTRICLE VOLUME; HEART VENTRICLE; HEART VENTRICLE HYPERTROPHY; HUMAN; MALE; MITRAL VALVE REGURGITATION; ONCOGENE C FOS; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

ADULT; AORTIC VALVE INSUFFICIENCY; CARDIOMEGALY; CARDIOMYOPATHY, DILATED; DNA PRIMERS; FEMALE; GENE EXPRESSION; GENES, FOS; GENES, IMMEDIATE-EARLY; GENES, JUN; GENES, MYC; HEART VENTRICLES; HUMANS; MALE; MITRAL VALVE INSUFFICIENCY; MYOCARDIUM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 1042288136     PISSN: 07673981     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0767-3981.2003.00212.x     Document Type: Article

References (24)

1. Ruwhof C., van der Laarse A. Mechanical stress-induced cardiac hypertrophy, mechanisms and signal transduction pathways. Cardiovasc. Res. (2000) 47 23-37.
2. Yamazaki T., Yazaki Y. Molecular basis of cardiac hypertrophy. Z. Kardiol. (2000) 89 1-6.
3. Hu Y., Metzler B., Xu Q. Discordant activation of stress-activated protein kinases or c-Jun NH2-terminal protein kinases in tissues of heat-stressed mice. J. Biol. Chem. (1997) 272 9113-9119.
4. Grohe C., Nouskas J., Vetter H., Neyses L. Effects of nisoldipine on endothelin-1-and angiotensin II-induced immediate/early gene expression and protein synthesis in adult rat ventricular cardiomyocytes. J. Cardiovasc. Pharmacol. (1994) 24 13-16.
5. Rozich J.D., Barnes M.A., Schmid P.G., Zile M.R., McDermott P.J., Cooper G.T. Load effects on gene expression during cardiac hypertrophy. J. Mol. Cell. Cardiol. (1995) 27 485-499.
6. Kim S., Iwao H. Activation of mitogen-activated protein kinases in cardiovascular hypertrophy and remodeling. Jpn. J. Pharmacol. (1999) 80 97-102.
7. Hayashida W., Kihara Y., Yasaka A., Inagaki K., Iwanaga Y., Sasayama S. Stage-specific differential activation of mitogen-activated protein kinases in hypertrophied and failing rat hearts. J. Mol. Cell. Cardiol. (2001) 33 733-744.
8. Pollack P.S., Pasquarello L.M., Budjak R. et al. Differential expression of c-jun and junD in end-stage human cardiomyopathy. J. Cell. Biochem. (1997) 65 245-253.
9. Yano M., Kim S., Izumi Y., Yamanaka S., Iwao H. Differential activation of cardiac c-jun amino-terminal kinase and extracellular signal-regulated kinase in angiotensin II-mediated hypertension. Circ. Res. (1998) 83 H752-H760.
10. Izumi Y., Kim S., Zhan Y., Namba M., Yasumoto H., Iwao H. Important role of angiotensin II-mediated c-Jun NH(2)-terminal kinase activation in cardiac hypertrophy in hypertensive rats. Hypertension (2000) 36 511-516.
11. Cook S.A., Sugden P.H., Clerk A. Activation of c-Jun N-terminal kinases and p38-mitogen-activated protein kinases in human heart failure secondary to ischaemic heart disease J. Mol. Cell. Cardiol. (1999) 31 1429-1434.
12. Yue P., Long C.S., Austin R., Chang K.C., Simpson P.C., Massie B.M. Post-infarction heart failure in the rat is associated with distinct alterations in cardiac myocyte molecular phenotype. J. Mol. Cell. Cardiol. (1998) 30 1615-1630.
13. Reiss K., Capasso J.M., Huang H.E., Meggs L.G., Li P., Anversa P. ANG II receptors, c-myc, and c-jun in myocytes after myocardial infarction and ventricular failure. Am. J. Physiol. (1993) 264 H760-H769.
14. Larsen T.H., Skar R., Frotjold E.K., Haukanes K., Greve G., Saetersdal T. Regional activation of the immediate-early response gene c-fos in infarcted rat hearts. Int. J. Exp. Pathol. (1998) 79 163-172.
15. Isoyama S., Nitta-Komatsubara Y. Acute and chronic adaptation to hemodynamic overload and ischemia in the aged heart. Heart Fail. Rev. (2002) 7 63-69.
16. Dzimiri N., Al-Bahnasi K., Afrane B., Al-Haleees Z. In vivo alterations in human myocardial early gene expression precede hypertrophy in left ventricular overload. Pharmacologist (2002) 44 LB4.
17. Dzimiri N., Basco C., Moorji A., Afrane B., Al-Halees Z. Characterization of lymphocyte beta 2-adrenoceptor signalling in patients with left ventricular volume overload disease. Clin. Exp. Pharmacol. Physiol. (2002) 29 181-188.
18. Chomczynski P. A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques (1993) 15 532-534.
19. Barrans J.D., Allen P.D., Stamatiou D., Dzau V.J., Liew C.C. Global gene expression profiling of end-stage dilated cardiomyopathy using a human cardiovascular-based cDNA microarray. Am. J. Pathol. (2002) 160 2035-2043.
20. Kolbeck-Ruhmkorff C., Horban A., Zimmer H.G. Effect of pressure and volume overload on proto-oncogene expression in the isolated working rat heart. Cardiovasc. Res. (1993) 27 1998-2004.
21. Hengstenberg C., Maisch B. Increased nuclear proto-oncogene expression in hypertrophic cardiomyopathy. Cardioscience (1993) 4 15-20.
22. Zimmer H.G. Catecholamine-induced cardiac hypertrophy, significance of proto-oncogene expression. J. Mol. Med. (1997) 75 849-859.
23. Horban A., Kolbeck-Ruhmkorff C., Zimmer H.G. Correlation between function and proto-oncogene expression in isolated working rat hearts under various overload conditions. J. Mol. Cell. Cardiol. (1997) 29 2903-2914.
24. Taketani S., Sawa Y., Ichikawa H. et al. Change of c-Myc expression and cardiac hypertrophy in patients with aortic valve replacement. Ann. Thorac. Surg. (2001) 71 1154-1159.